Even with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them.
Mondelez International Inc., which also makes Sour Patch Kids candy and Ritz crackers, is monitoring the impact of Ozempic and other GLP-1 drugs “quite carefully,” Chief Executive Officer Dirk van de Put said in an interview with Bloomberg TV.
Models that incorporate changes in behavior from the drugs and expected adoption rates predict only a modest impact on its sales, he added. “Those models predict that in 10 years’ time, it will have an effect between 0.5% and 1% of our volume,” he said, calling it a “margin of error.”
Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
